Tatva Chintan Pharma Chem Share Price
1669.50+73.30 (+4.59%)
+55.82% past 1 Year
News
Tatva Chintan approves Rs 200 crore greenfield capex for specialty chemicals
Equity
TATVA
Tatva Chintan Pharma Chem posts strong Q1 EBITDA growth and margin expansion
Equity
TATVA
Tatva Chintan Pharma Chem Q1 profit and revenue surge strongly year-on-year
Equity
TATVA
Tatva Chintan Pharma - Quaterly Results
Equity
TATVA
Tatva Chintan Pharma Chem reports sharp YoY expansion in Q4 EBITDA and margin
Equity
TATVA
Tatva Chintan Pharma Chem Q4 profit surges on strong revenue growth
Equity
TATVA
Tatva Chintan Pharma reports Profit after tax of 9.02 Crores, in the March 2026 quarter
Equity
TATVA
Tatva Chintan Pharma Chem informs about analyst meet
Equity
TATVA
Tatva Chintan Pharma Chem Faces 80% Natural Gas Supply Cap Under Government Order 2026.
Equity
TATVA
Tatva Chintan Pharma Chem informs about disclosure
Equity
TATVA
Tatva Chintan Pharma Chem informs about newspaper publication
Equity
TATVA
Tatva Chintan Pharma Chem Guides Agro and Pharma Intermediates Revenue Growth for 2027
Equity
TATVA
Tatva Chintan Pharma Chem Guides Electrolyte Salts to 7-8% Revenue Share by CY2026 from 1%.
Equity
TATVA
Tatva Chintan Pharma Chem Announces Jolva Greenfield Capex and Execution Timeline
Equity
TATVA
Tatva Chintan Pharma Chem Guides EBITDA Margins to 20-22% Range in FY27
Equity
TATVA
Tatva Chintan Pharma Chem Provides FY26-FY27 Revenue Growth Guidance of 20-30% YoY.
Equity
TATVA
Tatva Chintan Pharma Chem Management Guides for INR 850-900 Crores Revenue from Current Capacity in 2.5-3 Years.
Equity
TATVA
Tatva Chintan Pharma - Quaterly Results
Equity
TATVA
Tatva Chintan Pharma Q3 FY26 EBITDA Surges to Rs 25.60 Crores, Margin at 19.50% YoY.
Equity
TATVA
Tatva Chintan Pharma Chem Q3FY26 Earnings: Net Profit Rs 15.20 Crores, Revenue Rs 130 Crores YoY.
Equity
TATVA